Marcus, R., Avigdor, A., Greenbaum, U., Brown, S., Fried, S., Golan-Accav, N., Shem-Tov, N., Yerushalmi, R., Danylesko, I., Jacoby, E., Nagler, A., Shimoni, A., Itzhaki, O., Esensten, J., Valid, O. B., Ballweg, A., Deschênes-Simard, X., Luttwak, E., Shah, G., Scordo, M., Dahi, P., Perales, M.-A., Zuckerman, T., Devlin, S. M., Yehudai-Ofir, D., Khatib, H., Shibly, N., Shouval, R. and Beyar-Katz, O. (2020) “Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma : a multi-center propensity score-matched analysis”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2025.288419.